Bio-Rad Laboratories EPS - Earnings per Share 2010-2025 | BIO
- Bio-Rad Laboratories EPS for the quarter ending March 31, 2025 was $2.29, a 82.97% decline year-over-year.
- Bio-Rad Laboratories EPS for the twelve months ending March 31, 2025 was $-76.52, a 615.81% increase year-over-year.
- Bio-Rad Laboratories 2024 annual EPS was $-65.36, a 199.54% increase from 2023.
- Bio-Rad Laboratories 2023 annual EPS was $-21.82, a 82.08% decline from 2022.
- Bio-Rad Laboratories 2022 annual EPS was $-121.79, a 186.48% decline from 2021.
Bio-Rad Laboratories Annual EPS | |
---|---|
2024 | $-65.36 |
2023 | $-21.82 |
2022 | $-121.79 |
2021 | $140.83 |
2020 | $126.47 |
2019 | $58.27 |
2018 | $12.10 |
2017 | $4.07 |
2016 | $0.88 |
2015 | $3.71 |
2014 | $3.05 |
2013 | $2.69 |
2012 | $5.78 |
2011 | $6.29 |
2010 | $6.59 |
2009 | $5.20 |
Bio-Rad Laboratories Quarterly EPS | |
---|---|
2025-03-31 | $2.29 |
2024-12-31 | $-25.89 |
2024-09-30 | $23.34 |
2024-06-30 | $-76.26 |
2024-03-31 | $13.45 |
2023-12-31 | $11.81 |
2023-09-30 | $3.64 |
2023-06-30 | $-39.59 |
2023-03-31 | $2.32 |
2022-12-31 | $27.24 |
2022-09-30 | $-5.48 |
2022-06-30 | $-31.05 |
2022-03-31 | $-112.50 |
2021-12-31 | $-51.83 |
2021-09-30 | $129.96 |
2021-06-30 | $30.32 |
2021-03-31 | $32.38 |
2020-12-31 | $27.96 |
2020-09-30 | $43.64 |
2020-06-30 | $32.15 |
2020-03-31 | $22.72 |
2019-12-31 | $18.35 |
2019-09-30 | $-8.68 |
2019-06-30 | $19.86 |
2019-03-31 | $28.74 |
2018-12-31 | $-27.43 |
2018-09-30 | $8.89 |
2018-06-30 | $8.87 |
2018-03-31 | $21.77 |
2017-12-31 | $2.76 |
2017-09-30 | $0.73 |
2017-06-30 | $0.17 |
2017-03-31 | $0.41 |
2016-12-31 | $-0.77 |
2016-09-30 | $0.62 |
2016-06-30 | $0.61 |
2016-03-31 | $0.42 |
2015-12-31 | $1.54 |
2015-09-30 | $0.59 |
2015-06-30 | $0.97 |
2015-03-31 | $0.61 |
2014-12-31 | $1.34 |
2014-09-30 | $0.39 |
2014-06-30 | $1.09 |
2014-03-31 | $0.23 |
2013-12-31 | $1.04 |
2013-09-30 | $-0.25 |
2013-06-30 | $1.20 |
2013-03-31 | $0.70 |
2012-12-31 | $1.51 |
2012-09-30 | $1.49 |
2012-06-30 | $1.69 |
2012-03-31 | $1.09 |
2011-12-31 | $2.11 |
2011-09-30 | $1.61 |
2011-06-30 | $1.41 |
2011-03-31 | $1.16 |
2010-12-31 | $2.41 |
2010-09-30 | $1.59 |
2010-06-30 | $1.35 |
2010-03-31 | $1.24 |
2009-12-31 | $1.35 |
2009-09-30 | $1.38 |
2009-06-30 | $1.37 |
2009-03-31 | $1.10 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $6.723B | $2.567B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
Boston Scientific (BSX) | United States | $153.611B | 38.46 |
Stryker (SYK) | United States | $149.817B | 31.33 |
EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
Medtronic (MDT) | Ireland | $112.441B | 15.94 |
Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
ResMed (RMD) | United States | $37.597B | 28.24 |
GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
Agilent Technologies (A) | United States | $33.875B | 22.08 |
Terumo (TRUMY) | Japan | $24.770B | 32.17 |
Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
Insulet (PODD) | United States | $21.162B | 83.07 |
Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
Baxter (BAX) | United States | $15.236B | 11.38 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
Haemonetics (HAE) | United States | $3.609B | 16.44 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.334B | 27.70 |
ICU Medical (ICUI) | United States | $3.192B | 23.54 |
QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
AtriCure (ATRC) | United States | $1.561B | 0.00 |
Acuren (TIC) | United States | $1.375B | 0.00 |
AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
Neogen (NEOG) | United States | $1.081B | 13.83 |
BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
InMode (INMD) | Israel | $0.954B | 9.62 |
Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
Owens & Minor (OMI) | United States | $0.669B | 5.55 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
CeriBell (CBLL) | United States | $0.622B | 0.00 |
Evolus (EOLS) | United States | $0.589B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
Surmodics (SRDX) | United States | $0.424B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
Quanterix (QTRX) | United States | $0.315B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
Cerus (CERS) | United States | $0.277B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
ZimVie (ZIMV) | United States | $0.263B | 11.94 |
Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
Brainsway (BWAY) | Israel | $0.253B | 66.85 |
Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.218B | 6.14 |
TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Organigram Global (OGI) | Canada | $0.186B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
Omeros (OMER) | United States | $0.180B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
Apyx Medical (APYX) | United States | $0.098B | 0.00 |
Fonar (FONR) | United States | $0.096B | 12.37 |
Jin Medical (ZJYL) | China | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
MacroGenics (MGNX) | United States | $0.086B | 0.00 |
Veru (VERU) | United States | $0.086B | 0.00 |
Zynex (ZYXI) | United States | $0.076B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
Agape ATP (ATPC) | $0.070B | 0.00 | |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 58.29 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
Safety Shot (SHOT) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.10 |
Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |